Ansuvimab

http://dbpedia.org/resource/Ansuvimab an entity of type: Thing

Ansuvimab, sold under the brand name Ebanga, is a monoclonal antibody medication for the treatment of Zaire ebolavirus (Ebolavirus) infection. The most common symptoms include fever, tachycardia (fast heart rate), diarrhea, vomiting, hypotension (low blood pressure), tachypnea (fast breathing) and chills; however, these are also common symptoms of Ebolavirus infection. Ansuvimab was approved for medical use in the United States in December 2020. rdf:langString
rdf:langString Ansuvimab
xsd:integer 58757469
xsd:integer 1090912877
rdf:langString None
xsd:integer 6368
xsd:integer 2375952
rdf:langString DB16385
xsd:integer 9924
rdf:langString D11875
rdf:langString Rx-only
xsd:integer 1724
xsd:integer 1994
xsd:integer 44
rdf:langString u
rdf:langString Ansuvimab-zykl, mAb114
rdf:langString Zaire ebolavirus
rdf:langString Ebanga
rdf:langString mab
rdf:langString TG8IQ19NG2
rdf:langString Ansuvimab, sold under the brand name Ebanga, is a monoclonal antibody medication for the treatment of Zaire ebolavirus (Ebolavirus) infection. The most common symptoms include fever, tachycardia (fast heart rate), diarrhea, vomiting, hypotension (low blood pressure), tachypnea (fast breathing) and chills; however, these are also common symptoms of Ebolavirus infection. Ansuvimab was approved for medical use in the United States in December 2020.
rdf:langString Ansuvimab
rdf:langString mab
xsd:nonNegativeInteger 25207
rdf:langString Ebanga
xsd:string 2375952-29-5
xsd:string DB16385
xsd:string TG8IQ19NG2
xsd:string D11875

data from the linked data cloud